U. Nowakgottl et al., ACQUIRED VON-WILLEBRAND DISEASE IN MALIGNANT PERIPHERAL NEUROECTODERMAL TUMOR (PNET), Medical and pediatric oncology, 25(2), 1995, pp. 117-118
In week 12 of the EICESS 92 protocol a 12-year-old boy with pelvic PNE
T developed acquired von Willebrand disease: bleeding time was prolong
ed (>15 min) and von Willebrand factor antigen (54%) and ristocetin co
factor activity (50) were reduced. Platelet aggregations with thrombin
and collagen and the number of major platelet glycoproteins/per plate
let did not differ from the controls. After Haemate P(R) (Behring Werk
e, Marburg, Germany) bleeding time normalized and surgery could be per
formed without occurrence of bleeding episodes. Three weeks after surg
ery bleeding time, ristocetin cofactor activity, and von Willebrand fa
ctor antigen increased to normal paediatric values. Without occurrence
of further bleeding episodes the patient received another 10 courses
of polychemotherapy (EICESS 92). (C) 1995 Wiley-Liss, Inc.